Combination of Oncolytic Virus and Chemotherapy Shows Promise in Treating Triple-Negative Breast Cancer
Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with this subtype typically have a poorer prognosis compared with other breast cancers, suggesting the need for improved existingRead More…